Core Viewpoint - Ambac Financial Group (AMBC) is expected to report a year-over-year decline in earnings due to lower revenues, with a consensus outlook indicating a quarterly loss of $0.24 per share, representing a -233.3% change from the previous year [1][3]. Earnings Expectations - The upcoming earnings report is crucial for stock movement; better-than-expected results could drive the stock higher, while a miss may lead to a decline [2]. - The consensus estimate for revenues is projected at $55.59 million, down 47.1% from the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has been revised 25% higher in the last 30 days, reflecting a reassessment by analysts [4]. - Ambac's Most Accurate Estimate is higher than the Zacks Consensus Estimate, resulting in an Earnings ESP of +12.50%, indicating a likelihood of beating the consensus EPS estimate [12]. Earnings Surprise Prediction - The Zacks Earnings ESP model suggests that a positive Earnings ESP reading is a strong predictor of an earnings beat, especially when combined with a favorable Zacks Rank [10]. - Ambac currently holds a Zacks Rank of 3, which indicates a neutral outlook, but the positive Earnings ESP suggests potential for an earnings surprise [12]. Historical Performance - Ambac has not been able to beat consensus EPS estimates in any of the last four quarters, with the last reported quarter showing a significant miss of -85.71% [13][14]. Industry Comparison - Skyward Specialty Insurance (SKWD), another player in the insurance industry, is expected to report a year-over-year EPS increase of +7.5% and has a positive Earnings ESP of +2.51%, indicating a likely earnings beat [18][19].

Core Insights - S&P Global Inc. (SPGI) is set to release its second-quarter 2025 results on July 31, with a history of surpassing earnings estimates, averaging a surprise of 7.5% over the past four quarters [1][9]. Revenue Expectations - The Zacks Consensus Estimate for SPGI's revenues is $3.7 billion, reflecting a 3.7% increase from the same quarter last year, driven by strong core product demand and effective marketing initiatives [2][10]. - Market Intelligence revenues are projected at $1.2 billion, indicating a 3.7% year-over-year growth, supported by strong data analytics performance and positive M&A contributions [3][10]. - Ratings revenues are estimated at $1.1 billion, slightly above last year's figure, benefiting from increased issuance and refinancing activity [4]. - Commodity Insights revenues are expected to reach $539.8 million, showing a 4.6% year-over-year growth, aided by high demand for data and insights [5]. - Mobility revenues are projected at $420.1 million, reflecting a 5% increase from the previous year, driven by strong demand for CARFAX and effective marketing [6]. - Indices revenues are estimated at $397.2 million, implying a 2.1% year-over-year increase, primarily due to strong asset-linked fee growth [7]. Profitability Metrics - Adjusted EBITDA is estimated at $2.1 billion for the quarter, up 2.5% from the previous year, driven by top-line growth and strategic expense management [8]. - The consensus estimate for earnings per share is $4.25, indicating a 5.2% year-over-year increase, likely supported by margin expansion [8][10]. Earnings Prediction - The model predicts an earnings beat for SPGI, with an Earnings ESP of +0.52% and a Zacks Rank of 2 (Buy), enhancing the likelihood of exceeding earnings expectations [9].

Core Viewpoint - Bristol-Myers Squibb Company (BMY) is set to report its second-quarter 2025 results on July 31, with sales and earnings estimates at $11.38 billion and $1.18 per share, respectively. However, earnings estimates for 2025 and 2026 have seen a decline over the past month [1][5]. Financial Estimates - The current earnings estimate for Q2 2025 is $1.18, down from $1.55 30 days ago, reflecting a decrease of 29.34%. The earnings estimates for 2025 and 2026 have also decreased to $6.37 and $6.03, respectively [2][5]. - BMY has a strong earnings surprise history, beating estimates in the last four quarters with an average surprise of 20.16% [2]. Factors Influencing Q2 Results - Total quarterly revenues are expected to be negatively impacted by declining sales from the legacy portfolio, which includes drugs like Eliquis, Revlimid, and Pomalyst, primarily due to generic competition [4][5]. - Sales for Pomalyst are estimated at $727 million, while Eliquis is projected to generate $3.5 billion in sales [6][7]. Growth Portfolio Performance - The growth portfolio, which includes drugs like Opdivo, Reblozyl, and Camzyos, is expected to partially offset the decline in legacy drug sales. Opdivo sales are estimated at $2.4 billion, while Reblozyl is projected at $546 million [8][10][11]. - New drug Cobenfy for schizophrenia has shown promising sales growth, indicating a positive start for the newly launched product [12][18]. Strategic Initiatives - BMY has announced cost-cutting plans aiming to save $1.5 billion by 2025 and an additional $2 billion annually by 2027, which are expected to improve profitability [5][14]. - The company has entered a strategic collaboration with BioNTech for the co-development of a bispecific antibody, BNT327, which targets solid tumors [19][22]. Stock Performance and Valuation - BMY shares have declined by 14.4% year-to-date, underperforming the industry and the S&P 500 [16]. - The stock currently trades at a price/earnings ratio of 7.84x forward earnings, lower than its historical mean and the large-cap pharma industry average [20].

Core Insights - American Superconductor Corporation (AMSC) is expected to report first-quarter fiscal 2025 results on July 30, with anticipated revenues between $64 million and $68 million, reflecting a 61.7% year-over-year increase from the previous quarter's reported figure of $39.6 million [1][10] - The company forecasts non-GAAP earnings to exceed 10 cents per share, with the consensus estimate at 12 cents per share, indicating a 50% year-over-year increase [2][10] - AMSC has consistently surpassed earnings estimates in the past four quarters, with an average surprise of 241.2% [2] Revenue Drivers - The acquisition of NWL Inc. for $56.4 million in August 2024 is expected to positively impact both top and bottom lines in the first quarter [3] - Improved business model, increased bookings, and a strengthened balance sheet are anticipated to contribute to revenue growth [4] - The Grid segment is projected to generate revenues of $55.6 million, a 71.9% increase year-over-year, driven by rising demand for energy power and ship protection systems [5][10] - The Wind segment is expected to see revenues of $7.6 million, reflecting a 20% year-over-year growth, supported by increased shipments of 2-megawatt and 3-megawatt turbines [6][10] Challenges - Macroeconomic uncertainties and unfavorable foreign exchange fluctuations are noted as potential concerns for the company [7] Earnings Prediction Model - The current model does not predict a definitive earnings beat for AMSC, as it holds a Zacks Rank 4 (Sell) and an Earnings ESP of 0.00% [8][9]

Core Viewpoint - MGM Resorts International is expected to report a decline in both revenues and earnings per share (EPS) for the second quarter of 2025, influenced by softer operational trends and inflationary pressures [1][8]. Estimate Revisions - The Zacks Consensus Estimate for second-quarter EPS has risen to 58 cents from 55 cents, but this reflects a 32.6% decrease from 86 cents in the same quarter last year [2]. - Projected revenues are estimated at nearly $4.3 billion, indicating a slight decline of 0.6% from the previous year's quarter [2]. Factors Influencing Quarterly Results - The decline in MGM's top and bottom lines is attributed to lower casino activity, reduced non-gaming demand, and weaker average daily rates, compounded by ongoing inflation and a tight labor market [3]. - Contributions from casino, rooms, and food and beverage are expected to be lower, with estimates of $2.17 billion, $880 million, and $722 million respectively, compared to $2.21 billion, $899 million, and $802 million from the prior year [4]. Operational Insights - Elevated operating expenses and wage inflation are likely to exert margin pressure, although digital growth, strong Las Vegas operations, and robust group bookings are expected to support performance [5]. - For Las Vegas operations, revenue estimates for casino and rooms are pegged at $500 million and $775 million, respectively, showing growth from $485 million and $767 million in the prior year [6]. - Regional properties are anticipated to generate steady cash flow, with revenue estimates of $702 million and $80 million for casino and rooms, respectively, compared to $684 million and $79 million in the previous year [7]. Earnings Prediction Model - The current model does not predict an earnings beat for MGM Resorts, as the company has an Earnings ESP of -2.80% and a Zacks Rank of 3 (Hold) [9].

Core Viewpoint - Shell plc (SHEL) is expected to report second-quarter results on July 31, with earnings estimated at $1.13 per share and revenues of $73.7 billion, reflecting a significant year-over-year decline in earnings and a slight decrease in revenues [1][3]. Group 1: Q1 Performance and Historical Context - In the previous quarter, Shell reported earnings of $1.84 per ADS, surpassing the Zacks Consensus Estimate of $1.54, but revenues of $70.2 billion fell short by over 12% due to lower LNG sales [2]. - Shell has beaten the Zacks Consensus Estimate for earnings in three of the last four quarters, with an average earnings surprise of 1.7% [3]. Group 2: Factors Influencing Q2 Results - Shell's Integrated Gas division is expected to produce between 900,000 and 940,000 barrels of oil equivalent per day, a decrease from the previous quarter's 927,000 [4][8]. - LNG output is projected to be between 6.4 million and 6.8 million tons, with weaker gas trading results anticipated compared to Q1 [4]. - Traditional drilling production is expected to decline to 1.66-1.76 million barrels of oil equivalent per day due to maintenance and asset sales [4]. Group 3: Refining and Chemicals Outlook - Refining margins have improved, rising from $6.20 per barrel in Q1 to $8.90 per barrel in Q2, supported by better refinery utilization [5][8]. - The chemicals segment is expected to report a loss due to unplanned shutdowns at the Monaca plant, impacting overall quarterly results [5][8]. - The renewables and energy solutions segment's performance is projected to range from a $400 million loss to a $200 million profit [5]. Group 4: Earnings Prediction and Model Insights - The Zacks model indicates uncertainty in Shell's ability to beat earnings estimates for Q2, with an Earnings ESP of 0.00% as both the Most Accurate Estimate and the Zacks Consensus Estimate are at $1.13 per share [6][7][9]. - Shell currently holds a Zacks Rank 3, which does not enhance the predictive power of the Earnings ESP due to the 0.00% figure [9].

Key Takeaways Generac Holdings Inc. (GNRC) will report second-quarter 2025 results on July 30, before market open. The Zacks Consensus Estimate for second-quarter revenues is pegged at $1.02 billion, up 2.6% from the prior- year reported number. GNRC expects second-quarter net sales growth in the low single-digit range. The consensus estimate for earnings is pinned at $1.33 per share, down 1.5% year over year. The estimate has moved down 2 cents in the past seven days. GNRC beat the Zacks Consensus Estimate ...

Core Viewpoint - The AES Corporation is set to report its second-quarter 2025 results on July 31, 2025, with expectations of revenue growth and improved earnings per share despite challenges from extreme weather conditions [1][6][8]. Group 1: Upcoming Results Expectations - The Zacks Consensus Estimate for AES' revenues is $3.27 billion, indicating an 11.3% increase from the same quarter last year [6]. - The earnings per share (EPS) estimate is 43 cents, reflecting a 13.2% improvement year-over-year [6][8]. - The company experienced a negative earnings surprise of 27.03% in the last quarter but has a four-quarter average earnings surprise of 13.92% [1]. Group 2: Factors Influencing Performance - Mixed temperature patterns and above-normal precipitation during the April-June quarter are expected to have a moderate impact on quarterly revenues [2]. - Extreme weather events, including hail and thunderstorms, may have caused outages and negatively affected top-line performance [3]. - Favorable rate outcomes from previous quarters and increased energy demand from data center expansions are anticipated to positively contribute to revenue growth [4]. Group 3: Cost and Cash Position - Severe weather may have led to infrastructural damage, increasing operating expenses for restoration, which could hurt earnings [4]. - Solid sales growth expectations, cost-saving initiatives, and favorable returns from renewable projects are likely to support overall bottom-line performance [5]. - The divestment of a 30% stake in AES Ohio, completed in April 2025, is expected to enhance the company's cash position in the second quarter [5]. Group 4: Earnings Prediction Model - The current Zacks model does not predict an earnings beat for AES, with an Earnings ESP of -6.68% [7]. - AES holds a Zacks Rank of 3, indicating a neutral outlook [9].

Core Insights - IDEXX Laboratories, Inc. (IDXX) is scheduled to release its second-quarter 2025 results on August 4, before the market opens [1] - In the last reported quarter, the company achieved adjusted earnings per share (EPS) of $2.96, exceeding the Zacks Consensus Estimate by 1.37% [1] - The company has beaten earnings estimates in three of the last four quarters, with an average surprise of negative 0.09% [1] Revenue and EPS Estimates - The Zacks Consensus Estimate for Q2 revenues is $1.07 billion, reflecting a 6.3% increase from the previous year [2] - The Zacks Consensus Estimate for EPS is $3.31, indicating a rise of 35.7% year-over-year [2] - Earnings estimates have increased by 0.6% to $3.31 in the past 30 days [3] Performance Factors - The Companion Animal Group (CAG) is expected to show strong performance due to global net price improvements and higher volumes, particularly in diagnostics [4] - IDEXX VetLab consumables revenue growth is anticipated from higher price realization and volume increases, supported by an expanded active installed instrument base [4] - Reference laboratory diagnostic services are expected to see increased revenues from higher global price realization and testing volumes, although rapid assay revenues may be impacted by lower U.S. clinical visits [5] International and Innovation Impact - International CAG Diagnostic recurring revenues are likely to benefit from new business gains and an expanded premium instrument installed base [6] - IDEXX's recent innovations, such as the IDEXX Cancer Dx diagnostic panel, are expected to positively impact second-quarter revenues [7] - Growth in Veterinary Software, Services, and Diagnostic Imaging Systems is likely driven by higher subscription volumes and increased sales of diagnostic imaging systems [8] Segment Performance - The Water segment is projected to deliver solid revenues, benefiting from realized price increases and higher volumes, with an estimated 8.7% year-over-year improvement [10] - The Livestock, Poultry, and Dairy (LPD) division is expected to see a 3.9% year-over-year decrease in revenues for Q2 2025 [11] Earnings ESP and Zacks Rank - IDEXX Laboratories has an Earnings ESP of +0.34%, indicating a higher chance of beating estimates [12] - The company currently holds a Zacks Rank of 3 (Hold) [13]

Core Insights - The Kraft Heinz Company (KHC) is expected to report a decline in both revenue and earnings for the second quarter of 2025, with revenue estimated at $6.3 billion, reflecting a 2.9% decrease from the previous year [1] - The earnings consensus remains at 64 cents per share, indicating an 18% decline compared to the same quarter last year [2] Factors Impacting Results - KHC is facing challenges in volume performance due to changing consumer behavior and macroeconomic pressures such as tariffs and inflation, particularly affecting the U.S. Away from Home segment [3] - A projected 3.2 percentage point year-over-year decline in volume/mix is anticipated, leading to a similar drop in organic net sales [4] - Margin pressure is also a concern, with expectations of a 190 basis point contraction in adjusted gross margin, reaching 33.6% in Q2 2025, driven by unfavorable volume/mix shifts and rising costs [5] Strategic Initiatives - The company is focusing on growth through effective pricing strategies, operational efficiencies, and innovation, with its Brand Growth System expanding in emerging markets [6] Earnings Predictions - Despite the challenges, KHC has a positive Earnings ESP of +0.31% and a Zacks Rank of 3, suggesting a potential earnings beat [7]